Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

China · Delayed Price · Currency is CNY

31.37

-0.46 (-1.45%)

Feb 24, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology	657.95M	523.71M	529.94M	430.45M	269.47M
Biotechnology Growth	25.63%	-1.18%	23.11%	59.74%	55.05%
Total	657.95M	523.71M	529.94M	430.45M	269.47M
Total Growth	25.63%	-1.18%	23.11%	59.74%	55.05%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South China	226.79M	-	-	-	-
North China	99.45M	-	-	-	-
East China	163.92M	-	-	-	-
Southwest Region	68.17M	-	-	-	-
Northwest	17.79M	-	-	-	-
Central China	48.32M	-	-	-	-
Northeast China	17.34M	-	-	-	-
Taiwan	444.57K	-	-	-	-
U.S.	2.27M	-	-	-	-
Total	644.50M	-	-	-	-

Source: S&P Global Market Intelligence.